Importance of post-translational modifications on the function of key haemostatic proteins
Association of mean platelet volume with impaired myocardial reperfusion and short-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention
Risk of atherothrombotic events in patients after proximal deep-vein thrombosis
Neonates born to mothers with immune thrombocytopenic purpura
Changes in thrombin generation in children after cardiac surgery and ex-vivo response to blood products and haemostatic agents
A comparative study of tissue factor and kaolin on blood coagulation assays using rotational thromboelastometry and thromboelastography
Assessment of the frequency of regulatory T cells (CD4+CD25+CD127−) in children with hemophilia A
Efficacy and safety of eltrombopag in treatment-refractory primary immune thrombocytopenia
Measuring dabigatran with the dilute Russell viper venom confirm assay in an anticoagulation clinic population
Coagulation factor VIII, IX and XI levels in north Indian patients with venous thromboembolism
Effects of glycosaminoglycan from Mactra veneriformis on the protein C system and expression of relevant factors in human umbilical vein endothelial cells
High-sensitivity C-reactive protein and mean platelet volume as predictive values after percutaneous coronary intervention for long-term clinical outcomes
Sonoclot coagulation analysis
Protein Z efficiently depletes thrombin generation in disseminated intravascular coagulation with poor prognosis
Evaluation of prothrombin time and activated partial thromboplastin time mixing studies using an estimated factor correction method
Establishment of a prenatal diagnosis schedule as part of a prophylaxis program of factor XIII deficiency in the southeast of Iran
Autologous stem cell transplantation in immunoglobulin light chain amyloidosis with factor X deficiency
Two consecutive pregnancies in a patient with paroxysmal nocturnal haemoglobinuria treated with anticoagulant therapy at different doses
Infusion of angiotensin II increases fibrinolysis in healthy individuals but not in patients with familial combined hyperlipidemia